158 related articles for article (PubMed ID: 10798964)
21. Mechanisms of neurodegeneration in amyotrophic lateral sclerosis.
Cluskey S; Ramsden DB
Mol Pathol; 2001 Dec; 54(6):386-92. PubMed ID: 11724913
[TBL] [Abstract][Full Text] [Related]
22. Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading.
Subramaniam JR; Lyons WE; Liu J; Bartnikas TB; Rothstein J; Price DL; Cleveland DW; Gitlin JD; Wong PC
Nat Neurosci; 2002 Apr; 5(4):301-7. PubMed ID: 11889469
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis.
Chang-Hong R; Wada M; Koyama S; Kimura H; Arawaka S; Kawanami T; Kurita K; Kadoya T; Aoki M; Itoyama Y; Kato T
Exp Neurol; 2005 Jul; 194(1):203-11. PubMed ID: 15899257
[TBL] [Abstract][Full Text] [Related]
24. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
[TBL] [Abstract][Full Text] [Related]
25. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS).
Volkening K; Leystra-Lantz C; Yang W; Jaffee H; Strong MJ
Brain Res; 2009 Dec; 1305():168-82. PubMed ID: 19815002
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
[TBL] [Abstract][Full Text] [Related]
27. Amyotrophic lateral sclerosis-related mutant superoxide dismutase 1 aggregates inhibit 14-3-3-mediated cell survival by sequestration into the JUNQ compartment.
Park JH; Jang HR; Lee IY; Oh HK; Choi EJ; Rhim H; Kang S
Hum Mol Genet; 2017 Sep; 26(18):3615-3629. PubMed ID: 28666328
[TBL] [Abstract][Full Text] [Related]
28. Superoxide dismutase 1 mutants related to amyotrophic lateral sclerosis induce endoplasmic stress in neuro2a cells.
Oh YK; Shin KS; Yuan J; Kang SJ
J Neurochem; 2008 Feb; 104(4):993-1005. PubMed ID: 18233996
[TBL] [Abstract][Full Text] [Related]
29. Mutant enzyme provides new insights into the cause of ALS.
Marx J
Science; 1996 Jan; 271(5248):446-7. PubMed ID: 8560253
[No Abstract] [Full Text] [Related]
30. Zinc and copper in the pathogenesis of amyotrophic lateral sclerosis.
Elliott JL
Prog Neuropsychopharmacol Biol Psychiatry; 2001 Aug; 25(6):1169-85. PubMed ID: 11474839
[TBL] [Abstract][Full Text] [Related]
31. Pathophysiology of neurodegeneration in familial amyotrophic lateral sclerosis.
Vucic S; Kiernan MC
Curr Mol Med; 2009 Apr; 9(3):255-72. PubMed ID: 19355908
[TBL] [Abstract][Full Text] [Related]
32. Zinc pre-treatment enhances NMDAR-mediated excitotoxicity in cultured cortical neurons from SOD1(G93A) mouse, a model of amyotrophic lateral sclerosis.
Nutini M; Frazzini V; Marini C; Spalloni A; Sensi SL; Longone P
Neuropharmacology; 2011 Jun; 60(7-8):1200-8. PubMed ID: 21056589
[TBL] [Abstract][Full Text] [Related]
33. A drosophila model for amyotrophic lateral sclerosis reveals motor neuron damage by human SOD1.
Watson MR; Lagow RD; Xu K; Zhang B; Bonini NM
J Biol Chem; 2008 Sep; 283(36):24972-81. PubMed ID: 18596033
[TBL] [Abstract][Full Text] [Related]
34. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons.
Williamson TL; Cleveland DW
Nat Neurosci; 1999 Jan; 2(1):50-6. PubMed ID: 10195180
[TBL] [Abstract][Full Text] [Related]
35. Lack of apoptosis in mice with ALS.
Migheli A; Atzori C; Piva R; Tortarolo M; Girelli M; Schiffer D; Bendotti C
Nat Med; 1999 Sep; 5(9):966-7. PubMed ID: 10470053
[No Abstract] [Full Text] [Related]
36. Transgenic mouse models of amyotrophic lateral sclerosis.
Julien JP; Kriz J
Biochim Biophys Acta; 2006; 1762(11-12):1013-24. PubMed ID: 16675207
[TBL] [Abstract][Full Text] [Related]
37. Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice.
Hadano S; Mitsui S; Pan L; Otomo A; Kubo M; Sato K; Ono S; Onodera W; Abe K; Chen X; Koike M; Uchiyama Y; Aoki M; Warabi E; Yamamoto M; Ishii T; Yanagawa T; Shang HF; Yoshii F
Hum Mol Genet; 2016 Aug; 25(15):3321-3340. PubMed ID: 27439389
[TBL] [Abstract][Full Text] [Related]
38. Accumulation of neurofilaments and SOD1-immunoreactive products in a patient with familial amyotrophic lateral sclerosis with I113T SOD1 mutation.
Kokubo Y; Kuzuhara S; Narita Y; Kikugawa K; Nakano R; Inuzuka T; Tsuji S; Watanabe M; Miyazaki T; Murayama S; Ihara Y
Arch Neurol; 1999 Dec; 56(12):1506-8. PubMed ID: 10593307
[TBL] [Abstract][Full Text] [Related]
39. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA.
Wang J; Xu G; Slunt HH; Gonzales V; Coonfield M; Fromholt D; Copeland NG; Jenkins NA; Borchelt DR
Neurobiol Dis; 2005 Dec; 20(3):943-52. PubMed ID: 16046140
[TBL] [Abstract][Full Text] [Related]
40. Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons.
Lasiene J; Komine O; Fujimori-Tonou N; Powers B; Endo F; Watanabe S; Shijie J; Ravits J; Horner P; Misawa H; Yamanaka K
Acta Neuropathol Commun; 2016 Feb; 4():15. PubMed ID: 26891847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
